Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aethlon Medical (AEMD) Invested Capital (2016 - 2025)

Aethlon Medical filings provide 15 years of Invested Capital readings, the most recent being $5.1 million for Q1 2025.

  • On a quarterly basis, Invested Capital fell 11.15% to $5.1 million in Q1 2025 year-over-year; TTM through Mar 2025 was $5.1 million, a 11.15% decrease, with the full-year FY2025 number at $5.1 million, down 11.15% from a year prior.
  • Invested Capital hit $5.1 million in Q1 2025 for Aethlon Medical, up from $4.3 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $24.9 million in Q2 2021 to a low of $4.3 million in Q4 2024.
  • Median Invested Capital over the past 5 years was $13.1 million (2023), compared with a mean of $13.2 million.
  • Biggest five-year swings in Invested Capital: soared 81.46% in 2022 and later crashed 62.26% in 2024.
  • Aethlon Medical's Invested Capital stood at $20.7 million in 2021, then dropped by 15.56% to $17.5 million in 2022, then plummeted by 56.43% to $7.6 million in 2023, then plummeted by 43.06% to $4.3 million in 2024, then grew by 18.21% to $5.1 million in 2025.
  • The last three reported values for Invested Capital were $5.1 million (Q1 2025), $4.3 million (Q4 2024), and $6.0 million (Q3 2024) per Business Quant data.